Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 9 de 9
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Life Sci ; 51(19): 1479-84, 1992.
Artículo en Inglés | MEDLINE | ID: mdl-1435057

RESUMEN

Giant freshwater prawns, Macrobrachium rosenbergii de Man, were reared under three different lighting conditions: continuous darkness (DD), 12 hr of light and 12 hr of darkness (LD 12:12) and continuous light (LL). After one month, the prawns were sacrificed and optic lobes isolated from the eyestalks were determined for N-acetyltransferase (NAT) activities and melatonin concentrations. Gonads were weighed and examined under light microscopy. The optic lobes from LL prawns contained significantly higher activities of NAT than those from LD 12:12 prawns. The melatonin concentrations and size and histological features of the gonads from the three groups of prawns did not differ. The results indicate that continuous light increases NAT activities in the optic lobe of M. rosenbergii but has no drastic effect on gonadal growth.


Asunto(s)
Arilamina N-Acetiltransferasa/metabolismo , Luz , Palaemonidae/enzimología , Animales , Oscuridad , Femenino , Gónadas/anatomía & histología , Gónadas/enzimología , Masculino , Melatonina/metabolismo , Lóbulo Óptico de Animales no Mamíferos/enzimología , Tamaño de los Órganos , Periodicidad
2.
J Pineal Res ; 6(2): 111-9, 1989.
Artículo en Inglés | MEDLINE | ID: mdl-2915321

RESUMEN

Effects of melatonin on the ventral prostate of castrated rats supplemented with testosterone were studied using light microscopy. Stereological measurements were made of volume fractions of acini and stroma and surface fractions of glandular epithelium. From these figures and the weights of the glands, the volumes and surface areas were calculated, as well as the mean epithelial heights, mean acinar diameters, and mean distances between glandular acini. Doses of melatonin were varied, to verify its physiological and pharmacological effects. Castration without hormonal treatments produced atrophic changes, with decreases in acinar and stromal volume and widenings in the mean distances between the acini. None of these measurements differed among intact controls, sham-operated controls, and testosterone-supplemented castrated rats. In the castrated rats receiving both testosterone and melatonin, however, there were changes according to the doses of melatonin given. The animals receiving low doses of melatonin (50 and 400 micrograms daily) showed significant decreases in the volumes of the stroma and epithelium and the height of the epithelium. These stereological changes occurred without a significant reduction in the prostatic weights. The animals receiving the higher dose (800 micrograms daily) of melatonin showed no difference in any measurement compared with those of the testosterone-supplemented castrated rats. In rats receiving 2,000 micrograms of melatonin daily, there were significant reductions in the weights of the prostates and the volumes of the acini. These results suggest a direct action of melatonin on the ventral prostate, and the effects depend on the dose given.


Asunto(s)
Melatonina/farmacología , Próstata/efectos de los fármacos , Animales , Atrofia , Masculino , Tamaño de los Órganos/efectos de los fármacos , Próstata/patología , Ratas , Ratas Endogámicas
3.
J Pineal Res ; 4(2): 169-75, 1987.
Artículo en Inglés | MEDLINE | ID: mdl-3598851

RESUMEN

Dynamics of radioactive accumulation in rat greater salivary gland following systemic administration of 3H-melatonin was studied to determine a possible action of the hormone in the gland. Progressive decline of 3H-melatonin concentrations was found in the serum, lung, skeletal muscle, liver, kidney, and salivary gland during 60 min following the administration. On the contrary, there was a progressive accumulation of radioactive substance other than 3H-melatonin in the salivary gland but not in other tissues mentioned. The radioactivity was also progressively and preferentially localized in the nuclear fraction of the gland cells. These results suggest a possible direct action of melatonin derivative in rat salivary gland.


Asunto(s)
Melatonina/metabolismo , Glándulas Salivales/metabolismo , Animales , Núcleo Celular/metabolismo , Citoplasma/metabolismo , Riñón/metabolismo , Cinética , Hígado/metabolismo , Pulmón/metabolismo , Masculino , Músculos/metabolismo , Ratas , Ratas Endogámicas , Distribución Tisular , Tritio
4.
Life Sci ; 38(19): 1757-65, 1986 May 12.
Artículo en Inglés | MEDLINE | ID: mdl-3702605

RESUMEN

Radioactive concentrations were determined in serum, lung, hypothalamus, anterior pituitary, testis, and accessory sex organs of adult male rats at 2, 20, 30 and 60 min after intravenous 3H-melatonin administrations. The retention patterns of 3H-melatonin and other radioactive substance (3H-non-melatonin) in these tissues were compared. The anterior pituitary demonstrated best tissue retention with highest concentration of 3H-melatonin. The testis and prostate gland accumulated 3H-non-melatonin in an increasing manner from 2 to 60 min. The radioactive substances were also preferentially and progressively located in the nuclear fraction of the anterior pituitary, hypothalamus, testis, and prostate gland. This study leads to the following suggestions: the anterior pituitary is another target organ of melatonin; melatonin is converted into other active material which exerts its action in the testis and prostate gland; melatonin and its active derivative exert their action through the nuclei of their respective cells.


Asunto(s)
Genitales Masculinos/metabolismo , Hipotálamo/metabolismo , Melatonina/metabolismo , Adenohipófisis/metabolismo , Animales , Núcleo Celular/metabolismo , Citoplasma/metabolismo , Epidídimo/metabolismo , Pulmón/metabolismo , Masculino , Próstata/metabolismo , Ratas , Vesículas Seminales/metabolismo , Testículo/metabolismo
7.
Acta Endocrinol (Copenh) ; 91(1): 59-69, 1979 May.
Artículo en Inglés | MEDLINE | ID: mdl-572125

RESUMEN

This study investigated the ability of continuously available melatonin (from sc melatonin-beeswax pellets that were implanted bi-weekly) in overcoming the antigonadotrophic action of single daily melatonin (25 microgram) injections given late in the light period to female Syrian hamsters kept in light:dark cycles of 14:10. The melatonin-beeswax pellets contained either 1, 50, 500 microgram, 1 or 10 mg melatonin and 25 mg beeswax. Daily melatonin injections into hamsters implanted with beeswax only caused vaginal acyclicity in 60% of the animals within 6 weeks. After 10 weeks of treatment, uterine weights and pituitary levels of immunoreactive prolactin were still greatly depressed. Beeswax pellets containing either 500 microgram, 1 or 10 mg melatonin overcame the inhibitory effects of daily melatonin injections. Thus, the vaginal cycles and pituitary hormone levels of these animals were indistinguishable from those of untreated control animals. Beeswax pellets containing either 1 or 50 microgram melatonin were incapable of counteracting the antigonadotrophic effects of daily injections of melatonin. This is the first report that continuously available melatonin can negate the effects of daily injections of melatonin in female hamsters. When measured after 10 weeks, none of the treatment procedures significantly influenced circulating levels of luteinizing hormone or prolactin.


Asunto(s)
Melatonina/farmacología , Reproducción/efectos de los fármacos , Animales , Cricetinae , Implantes de Medicamentos , Estro/efectos de los fármacos , Femenino , Inyecciones Subcutáneas , Hormona Luteinizante/sangre , Melatonina/administración & dosificación , Tamaño de los Órganos/efectos de los fármacos , Ovario/efectos de los fármacos , Adenohipófisis/efectos de los fármacos , Embarazo , Prolactina/sangre , Útero/efectos de los fármacos
8.
Mol Cell Endocrinol ; 14(1): 59-71, 1979 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-378736

RESUMEN

Treatment of unanesthetized castrated adult male rats every 3 h for 48 h with either 5 microgram of arginine vasotocin (AVT) and/or 1 microgram luteinizing hormone-releasing hormone (LRH) caused a significant inhibition of plasma levels of luteinizing hormone (LH) and compared to castrated control rats receiving diluent only. However, the intravenous (iv) injection of 1 microgram of AVT into urethane-anesthetized male rats which had been castrated for 0, 24 or 48 h did not affect plasma levels of LH at 10, 20 or 60 min following injection compared to their respective diluent-treated castrated control rats. Similarly, the iv injection of either 100 ng, 1 microgram or 10 microgram AVT was unable to acutely affect plasma levels of LH in intact male rats. Following the iv injection of 2 doses of 50 ng LRH spaced 1 h apart in anesthetized castrated male rats, 2 peaks of equal magnitude in plasma LH were noted. Castrated rats treated with 2 injections spaced 1 h apart of LRH + AVT had significantly higher plasma levels of LH than did rats treated with LRH alone. In subsequent studies, both AVT and arginine vasopressin were observed to augment the plasma response of LH to an injection of LRH whereas oxytocin had no effect. A single injection of AVT + LRH significantly augmented the plasma titers of LH compared to levels observed in LRH-treated control rats as did a second injection 1 h later. The administration of cyproterone acetate sc for 2 days by itself had no effect on plasma LH but in conjunction with LRH caused a marked rise in plasma LH compared to intact rats treated with LRH alone. AVT in combination with LRH and cyproterone acetate caused a significant elevation in plasma LH at 60 min post-injection when compared to plasma levels of rats treated with LRH alone or the combination of LRH and cyproterone acetate. It is concluded that acute intravenous injections of AVT augment the LH-releasing activity of LRH; chronic treatment for 48 h, however, with LRH + AVT leads to a significant depression of plasma LH perhaps due to an exhaustion of the releasable pool of LH in the anterior pituitary.


Asunto(s)
Ciproterona/farmacología , Hormona Liberadora de Gonadotropina/farmacología , Hormona Luteinizante/sangre , Vasotocina/farmacología , Animales , Arginina Vasopresina/farmacología , Castración , Hormona Liberadora de Gonadotropina/administración & dosificación , Masculino , Oxitocina/farmacología , Adenohipófisis/metabolismo , Ratas , Factores de Tiempo , Vasotocina/administración & dosificación
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA